Skip to main content
  • Main menu
  • User menu
  • Search

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleConference Proceedings

Proceedings of the 2023 Viral Clearance Symposium: 2023 VCS Summary, Pending Questions, and Next Steps

David Roush and Glen Bolton
PDA Journal of Pharmaceutical Science and Technology March 2024, 78 (2) 141-143; DOI: https://doi.org/10.5731/pdajpst.2024.002240
David Roush
1Roush Biopharma Panacea, Colts Neck, NJ 07722; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rbpceo@roushbiopharmapanacea.company
Glen Bolton
2Amgen, Cambridge, MA 02142
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Bolton G.
    Proceedings of the 2019 Viral Clearance Symposium, Session 8. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments and Actions. PDA J. Pharm. Sci. Technol. 2022, 76 (4), 362–367.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  2. 2.↵
    1. O’Donnell S.,
    2. Bolton G.
    Proceedings of the 2019 Viral Clearance Symposium, Session 6: Virus-Retentive Filtration. PDA J. Pharm. Sci. Technol. 2022, 76 (4), 348-357.
    OpenUrlGoogle Scholar
  3. 3.↵
    1. Mattila J.,
    2. Curtis S.,
    3. Webb-Vargas Y.,
    4. Wilson E.,
    5. Galperina O.,
    6. Roush D.,
    7. Tobler S.,
    8. Stanley B.,
    9. Clark M.,
    10. Weaver J.,
    11. Pike J.,
    12. Yu D.,
    13. Li X.,
    14. Flicker A.,
    15. Kindermann J.,
    16. Schuelke N.,
    17. Whitcombe R.,
    18. Bennett L.
    Retrospective Evaluation of Cycled Resin in Viral Clearance Studies-A Multiple Company Collaboration. PDA J. Pharm. Sci. Technol. 2019, 73 (5), 470–486.
    OpenUrlAbstract/FREE Full TextGoogle Scholar
  4. 4.↵
    1. Alam M.,
    2. Joshi R.,
    3. Chung W. K.,
    4. Lewandowski A.,
    5. Ghose S.
    Utilizing Viral Surrogates as High Throughput Screening Tools in Chromatography Viral Clearance Studies. Presented at the ACS Fall 2023 National Meeting, San Francisco, CA, August 13-17, 2023.
    Google Scholar
  5. 5.↵
    1. Doss H.,
    2. Zha R.,
    3. Przybycien T.
    Fluorescent Viral Surrogates for Simulation of Non-Enveloped Viral Clearance Behavior Across Platform Downstream Unit Operations. Presented at the ACS Fall 2023 National Meeting, San Francisco, CA, August 13-17, 2023.
    Google Scholar
  6. 6.↵
    1. Dyer R.,
    2. McGinnis J.,
    3. Song Y.,
    4. Jenkins L.,
    5. Chen J.,
    6. Sharma S.,
    7. Ghose S.,
    8. Li Z.
    Evaluation of Cost-Effective Viral Surrogates for Viral Clearance Studies for Bioprocessing. Presented at the ACS Fall 2023 National Meeting, San Francisco, CA, August 13-17, 2023.
    Google Scholar
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 78 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Proceedings of the 2023 Viral Clearance Symposium: 2023 VCS Summary, Pending Questions, and Next Steps
David Roush, Glen Bolton
PDA Journal of Pharmaceutical Science and Technology Mar 2024, 78 (2) 141-143; DOI: 10.5731/pdajpst.2024.002240
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget

Jump to section

  • Article
    • Abstract
    • Resolution of Key Questions from 2019 VCS
    • Conflict of Interest Statement
    • References
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Proceedings of the 2023 Viral Clearance Symposium, Session 1: Regulatory Updates
  • Proceedings of the 2023 Viral Clearance Symposium, Session 4: Continuous Processing
  • Proceedings of the 2023 Viral Clearance Symposium, Session 7: Up- and Downstream Virus Retentive Filtration
Show more Conference Proceedings

Similar Articles

Keywords

  • Viral clearance
  • Viral Safety
  • Viral Clearance Symposium
  • Upstream processing
  • Downstream processing
  • Resin lifetime
  • Facility risk mitigation
  • Submission
  • Strategy
  • Next-generation sequencing
  • Modular viral clearance
  • Depth filtration
  • Regulatory agencies
  • FDA
  • PEI
  • Regulatory perspective
  • Continuous processing

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Proceedings of the 2023 Viral Clearance Symposium: 2023 VCS Summary, Pending Questions, and Next Steps
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Proceedings of the 2023 Viral Clearance Symposium: 2023 VCS Summary, Pending Questions, and Next Steps
David Roush, Glen Bolton
PDA Journal of Pharmaceutical Science and Technology Mar 2024, 78 (2) 141-143; DOI: 10.5731/pdajpst.2024.002240

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.